Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph, Prakash Deedwania, Tushar Acharya, et al.
Circulation (2022) Vol. 145, Iss. 9
Open Access | Times Cited: 366

Showing 26-50 of 366 citing articles:

Atherosclerotic Disease
Amanda Maria Morrison, Alexander E. Sullivan, Aaron W. Aday
Medical Clinics of North America (2023) Vol. 107, Iss. 5, pp. 793-805
Open Access | Times Cited: 25
Drug Therapies for Diabetes
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 23
Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis
María A. Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal (2024)
Open Access | Times Cited: 14
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
Kan Huang, Zilun Li, Xi He, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 598-616.e9
Closed Access | Times Cited: 12
Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity
Zihao Huang, Xiaodong Zhuang, Rihua Huang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e240219-e240219
Open Access | Times Cited: 11
Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
Shujin Wang, Yinying Han, Ruimin Liu, et al.
Circulation Research (2024) Vol. 134, Iss. 5, pp. 505-525
Open Access | Times Cited: 10
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure
Giovanna Gallo, Massimo Volpe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2484-2484
Open Access | Times Cited: 10
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
Fatemeh Taktaz, Rosaria Anna Fontanella, Lucia Scisciola, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy
Magdalena Walicka, Arkadiusz Krysiński, Giusy Rita Maria La Rosa, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 5, pp. 103044-103044
Open Access | Times Cited: 8
Diabetes in spotlight: current knowledge and perspectives of photobiomodulation utilization
Quentin Perrier, Cécile Moro, Sandrine Lablanche
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Engineered exosomes as a prospective therapy for diabetic foot ulcers
Lifei Guo, Dan Xiao, Helin Xing, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 7
Cortisol and cardiometabolic disease: a target for advancing health equity
Robin Ortiz, Bjorn Kluwe, Sophie A. Lazarus, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 786-797
Open Access | Times Cited: 27
The mediating effect of self-efficacy on the relationship between diabetes self-management ability and patient activation in older adults with type 2 diabetes
Anqi Zhang, Jinsong Wang, Xiaojuan Wan, et al.
Geriatric Nursing (2023) Vol. 51, pp. 136-142
Closed Access | Times Cited: 19
Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
Junyu Pei, Xiaopu Wang, Zeyu Pei, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Practical considerations for the use of SGLT‐2 inhibitors in the Asia–Pacific countries—An expert consensus statement
Adrian Liew, Aida Lydia, Bien J. Matawaran, et al.
Nephrology (2023) Vol. 28, Iss. 8, pp. 415-424
Open Access | Times Cited: 17
Comprehensiveness, Accuracy, and Readability of Exercise Recommendations Provided by an AI-Based Chatbot: Mixed Methods Study
Amanda L. Zaleski, Rachel S. Berkowsky, Kelly Jean Thomas Craig, et al.
JMIR Medical Education (2024) Vol. 10, pp. e51308-e51308
Open Access | Times Cited: 7
Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review
Huifang Guan, Jiaxing Tian, Ying Wang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Retinal microcirculation: A window into systemic circulation and metabolic disease
Yue Yuan, Meiyuan Dong, Song Wen, et al.
Experimental Eye Research (2024) Vol. 242, pp. 109885-109885
Closed Access | Times Cited: 6
Assessment of Cardiovascular Risk Categories and Achievement of Therapeutic Targets in European Patients with Type 2 Diabetes
Delia Reurean‐Pintilei, Claudia-Gabriela Potcovaru, Teodor Salmen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2196-2196
Open Access | Times Cited: 6
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, Javier Uribe, Nixa Olvares, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 4, pp. 101501-101501
Open Access | Times Cited: 6
Gut-targeted therapies for type 2 diabetes mellitus: A review
Tiancheng Xu, Yun Liu, Zhi Yu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 1, pp. 1-8
Open Access | Times Cited: 5
Sleep patterns and risks of incident cardiovascular disease and mortality among people with type 2 diabetes: a prospective study of the UK Biobank
Jinxia Hu, Xuanyang Wang, Licheng Cheng, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta‐Analysis
Saixian Shi, Xiaofeng Li, Ye Chen, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
Visit-to-visit lipid variability on long-term major adverse cardiovascular events: a prospective multicentre cohort from the CORE-Thailand registry
Chutithep Teekaput, Kitti Thiankhaw, Wanwarang Wongcharoen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring the Association of Area of Deprivation Index (ADI) and cardiovascular risk factors in South Florida
Juan M. González, Martha Duarte, Karina Gattamorta, et al.
Discover Health Systems (2025) Vol. 4, Iss. 1
Open Access

Scroll to top